FDA reportedly plans to authorize Pfizer’s COVID vaccine for teenagers 12-15 in days

Vials with COVID-19 Vaccine labels showing logos of pharmaceutical company Pfizer and German biotechnology company BioNTech.

Enlarge / Vials with COVID-19 Vaccine labels exhibiting logos of pharmaceutical firm Pfizer and German biotechnology firm BioNTech. (credit score: Getty | Photonews)

The Meals and Drug Administration is planning to authorize the usage of Pfizer-BioNTech’s COVID-19 vaccine in adolescents 12 to 15 years outdated later this week or early subsequent week, in keeping with a report by The New York Occasions.

The Occasions cited unnamed federal officers who didn’t have authorization to talk publicly in regards to the FDA’s plans. If the FDA does authorize use of the vaccine within the teen group within the week, the Facilities for Illness Management and Prevention’s vaccine advisory panel will probably meet a day later to evaluate the scientific trial knowledge and make a advice on use, the Occasions reported.

On March 31, Pfizer introduced that the vaccine fully protected adolescents ages 12 to 15 towards COVID-19 in a small Section III scientific trial. The vaccine was additionally well-tolerated within the age group, producing primarily commonplace unwanted side effects.

Learn 5 remaining paragraphs | Feedback

Tagged : / / / / / /

Leave a Reply

Your email address will not be published. Required fields are marked *